© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

SRI

Top section

Top section

France's new €8bn 30 year grabs record demand, performs in secondary

◆ AFT's Antoine Deruennes says 'clear message' showed demand for 30 year ◆ Speedy execution before US employment data ◆ Green OAT syndication next
Deal will bring fourth major multilateral development bank to the market

Fidelidade offers rare Portugese insurance tier two

◆ Refi deal came as issuer prepares IPO ◆ Deal extends the insurer's tier two curve by 10 years ◆ 'Strong bid' for Iberian FIG credit, says rival banker

REN runs into euros with tight EuGB deal

◆ Portuguese utility firm powers up EuGB curve ◆ Sub-benchmark trade's book proves sticky ◆ Deal lands through fair value
Deal will bring fourth major multilateral development bank to the market
Sub-sections
  • Chongqing Pharmaceutical (Group) Co is making its debut in the loan market for $150m. It is set to directly compete against a larger Chinese state-owned peer that is also testing lenders’ appetite for a new fundraising.
  • Equity markets were reeling this week as investors became more defensive in the face of rising Covid-19 cases across the world. Sources say that despite some countries, such as the UK, lifting Covid-19 restrictions, equity capital markets investors are bedding in for the pandemic to drag on.
  • There is good reason for cautious optimism when it comes to non-performing loans, despite the dire predictions made last summer. Italy, which has been dogged by NPL problems for years, is a prime example of how well things appear to be turning out, more than a year after the start of the pandemic.